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Background: Nano-hydroxyapatite (nHA) is a potential ideal biomaterial for bone regeneration. However, studies
have yet to characterize the behavior of human osteoblasts derived from alveolar bone on nHA. Thus, the aim of
the present study was to evaluate the influence of nHA on the adhesion, proliferation and differentiation of these
alveolar bone-derived cells.
Methods: Primary human alveolar osteoblasts were collected from the alveolar ridge of a male periodontal patient
during osseous resective surgery and grown on culture plates coated with either polylysine or polylysine with
nano-hydroxyapatite (POL/nHA) composite. The cells were grown and observed for 14 days, and then assessed for
potential modifications to osteoblasts homeostasis as evaluated by quantitative reverse transcriptase-polymerase
chain reaction (real time RT-PCR), scanning electron microscopy and atomic force microscopy.
Results: Real time PCR revealed a significant increase in the expression of the selected markers of osteoblast
differentiation (bone morphogenetic protein (BMP)-2,-5,-7, ALP, COLL-1A2, OC, ON) in cells grown on the POL/nHA
substrate. In addition, as compared with the POL surface, cells grown on the POL/nHA substrate demonstrated
better osteoconductive properties, as demonstrated by the increase in adhesion and spreading, likely as a result
of the increased surface roughness of the composite.
Conclusions: The increased expression of BMPs and osteoinductive biomarkers suggest that nano-hydroxyapatite
may stimulate the proliferation and differentiation of local alveolar osteoblasts and thus encourage bone regeneration
at sites of alveolar bone regeneration.
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The main concern of periodontology is the rehabilitation
of periodontally compromised teeth, possibly aiming at
the complete periodontal tissue regeneration [1]. Ideally,
this process would include the formation of new bone,
new periodontal ligament and new cementum, or rather
a new attachment over the root that has previously been
deprived of all the attachment apparatus [2]. The thera-
peutic approaches attempting to achieve this objective in-
clude the use of different grafting materials (autogenous,* Correspondence: matteo.saccucci@uniroma1.it
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riers for Guided Tissue Regeneration (GTR), enamel
matrix-derived proteins, and various growth factors [3,4].
It is assumed that the use of bone grafts or alloplastic
materials would result both in the regrowth of alveolar
bone and the formation of a new cementum layer with
inserted collagen fibers onto the previously periodontitis-
involved root surface [5]. The mechanism of action may
be either via the stimulation of osteogenesis (new bone
formation from the bone-forming cells contained in the
graft), osteoconduction (when the graft serves as a scaffold
for bone formation from the adjacent host bone), or
osteoinduction (the matrix of the bone graft contains
bone-inducing substances that result in bone formation intd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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plastic materials are presumed to promote bone healing
through osteoconduction and subsequently behave as a
scaffold for this process [5].
An ideal scaffold is a biocompatible material that pro-
vides appropriate mechanical support [7]. It should
possess a structure similar to the native extracellular
matrix, exhibit favorable surface properties, and lead to
an increase in adhesion, proliferation and differenti-
ation of osteoblastic cells [7]. Hydroxyapatite (HA) [Ca5
(PO4)3 OH] is an alloplastic material, chemically similar
to the inorganic component of bone matrix that trans-
lates these properties in a valuable and optimal biocom-
patibility [7]. When HA is grafted beneath a healthy
periosteum and well-vascularized bone, it first becomes
integrated by a clot [8] and then releases phosphate
ions into the surrounding environment, which stimu-
lates neo-osteogenesis.
A fundamental factor governing optimal integration of
HA with bone is the dimensions of the crystals. HA par-
ticles with dimensions closer to the size of natural crys-
tals found in vertebrate hard tissues (i.e., ranging from 1
to 10 nm), are now available [9], and they have been re-
ported to mimic the extracellular matrix of bone in size
and structure [10]. In vitro studies conducted with the
purpose of understanding the mechanism of action of
this nano-sized material have described a stimulatory ef-
fect on mesenchymal stem cells [11], an increase in pro-
tein absorption and osteoblast adhesion as compared
with traditional micro-sized HA [12,13], stimulation of
human osteoblast-like cell proliferation resulting in bone
formation [14], and the stimulation of PDL cell attach-
ment [15]. Despite this, there is little information to date
regarding the responses of human alveolar osteoblasts in
contact with this grafting material once the bone defect
is filled. Thus, the aim of our study was to evaluate
in vitro the effects of nHA on the adhesion and prolifer-
ation of human alveolar osteoblasts and to determine
the impact that this alloplastic material has on the ex-
pression of biomarkers of bone formation during HA-
mediated periodontal bone regeneration.
Methods
Isolation of human primary osteoblasts
Fresh human bone removed from the alveolar crest
were obtained with approval from the Ethical Commit-
tee of Sapienza University of Rome and informed pa-
tient consent.
Primary human alveolar osteoblasts (hOBs) were har-
vested from a 53-year-old male periodontal patient during
resective periodontal surgery according to a previously
validated protocol [16,17].
Harvested bone specimens were stored in Hank’s Bal-
anced Salt Solution (HBSS, Sigma-Aldrich, St. Louis, MO)containing 100 U/ml penicillin and 100 mg/ml strepto-
mycin until processing. For processing, bone samples were
rinsed in sterile phosphate-buffered saline (PBS), pH 7.4,
fragmented with a scalpel, and digested in solution of 1
mg/ml type IV collagenase and 0.25% trypsin (in PBS) at
37°C for 30 min with agitation, followed two additional di-
gestion stages for 40 min and 90 min, as previously de-
scribed [18,19]. Cells obtained from the second and third
digestions were collected, centrifuged and resuspended in
Dulbecco’s Modified Eagles Medium (DMEM, Gibco-
BRL, Rockville, MD) supplemented with 50 U/ml penicil-
lin, 50 μg/ml streptomycin, 4 mmol/l L-glutamine and
10% of fetal bovine serum (FBS, Hyclone, Thermo Scien-
tific, Wilmington, DE). Cells adhesion, proliferation and
morphology were visually inspected by microscopy (Nikon
Eclipse TS100, Nikon, Tokyo, Japan) over the 2-week time
frame. After the cells reached 70-80% confluence, they
were detached with trypsin-EDTA, harvested and used for
experiments between passages 2 and 4.
Poly-L-lysine and Poly-L-lysine-nHA coating preparation
One milliliter per 25 cm2 of 0.01% poly-L-lysine solution
(POL, Bioreagent, mol wt 150,000-300,000, sterile-
filtered, Sigma-Aldrich) was used to coat the surfaces of
Petri plates. Samples were gently shaken at 4°C at 1200
rpm for 10 min to homogenize stratification. The sur-
faces were then rinsed with sterile water and allowed to
dry at room temperature. Subsequently, 10 mg of nHA
powder (Ghimas Spa, Casalecchio di Reno, BO, Italy)
was resuspended in 1 ml of sterile water and used to
coat the POL-treated plates. Finally, coated surfaces
were rinsed with sterile water and allowed to dry.
Osteoblasts-POL and osteoblasts-POL-nHA samples
preparation
Osteoblast behavior was examined on coated plates
using two tests: in Test 1, plates coated only with POL
were seeded with hOBs onto at a density of 2 × 104 cells/
cm2; in Test 2, hOBs were seeded at the same density
onto plates coated with POL and nHA powder. Samples
of Test 1 and Test 2 were cultured under the same ex-
perimental conditions (95% humidity, 5% CO2, 37°C) in
DMEM containing 10% FBS. Experiments were per-
formed in triplicate and repeated three times each.
Scanning electron microscopy
Surface properties of the coated plates and osteoblast
morphology were visually investigated by scanning elec-
tron microscopy (SEM). After 24 h of culture on POL or
POL-nHA coated surfaces, samples were rinsed twice with
PBS, fixed in 2.5% glutaraldehyde for 1 h, rinsed with
distilled water, dehydrated with graded concentrations
of alcohol (50%, 70%, 90%, 100% ethanol) and finally
treated with CO2 at the top-critical point. Specimens
Table 1 Human primers used in RT-PCR for
Glyceraldehyde-3 phosphate-dehydrogenase (GAPDH),
alkaline phosphatase (ALP), A2 pro-collagen type 1 chain
(COLL-1A2), bone morphogenetic protein-2,-5,-7
(BMP-2,-5,-7)
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carbon tape and then coated with a 10-nm gold layer
(Coating Unit E5000, Polaron Ltd. Watford, UK). Speci-
mens were observed with SEM (Leo 1450VP, Carl Zeiss,
Jena, Germany) at various magnifications, using sec-
ondary electrons at 15 kV.
Atomic force microscopy
Atomic force microscopy (AFM) was carried out using a
Nanonics Imaging AFM system (Jerusalem, Israel) in a no
contact mode and a reference voltage of 0.8–1.0 V between
the tip and the sample surface during all experiments.
Gene expression
After 14 days of culture on POL and POL-nHA surfaces,
RNA was extracted according to the protocol previously
described [18]. RNA was reversed transcribed using Taq-
Man reverse transcription kit (Applied Biosystems, Life
Technologies, Foster City, CA), using random hexamers.
Real time PCR was then performed using SYBR green
gene expression assay (Applied Biosystems) on an ABI
Prism 7300 Real Time PCR system (Applied Biosystems)
to assess for changes in the expression of osteogenic
markers: alkaline phosphatase (ALP), A2 pro-collagen
type 1 chain (COLL-1A2), bone morphogenetic protein
(BMP)-2, BMP-5, BMP-7, osteocalcin and osteonectin.
Glyceraldehyde-3 phosphate-dehydrogenase (GAPDH)
was used as an endogenous control. Sequences were de-
signed using Primer Express software (Applied Biosys-
tems) and synthesized by Primm (Milan, Italy). Primers
are listed in Table 1. Gene expression was analyzed ac-
cording to the ΔΔCT method, with the expression levels
of Test 2 (POL/nHA) samples normalized towards Test
1 (POL) values.
Statistical analysis of data
The Statistical Package for Social Sciences (SPPS v15.0,
SPSS Inc. Chicago, IL) was used for statistical analysis.
Analyses were performed using Student’s t-test. Signifi-
cance was set at p < 0.05.
Results
Human primary osteoblasts extraction and culture
Osteoblasts successfully attached to the substrate sur-
faces and were observed to undergo proliferation from
day 4 to day 14, as determine by visual inspection by mi-
croscopy (Figure 1A–C).
POL and POL-nHA surface roughness properties
The roughness of both substrate surfaces was evaluated
by SEM and AFM. The nanometric surface roughness
evaluated by AFM was 49.7 rms/nm for POL-nHA and
6.3 rms/nm for POL. Thus, plates covered in POL-nHA
showed a 7.89-fold higher nanometric superficial roughnesscompared with POL plates (Figure 2A-D). Additionally,
SEM observations revealed the morphology of the nHA
particles to have a rod-like shape of 70–90 nm in diameter.
Effect of nano-hydroxyapatite on osteoblast adhesion and
proliferation
The potential morphological modifications to hOBs were
evaluated after the cells were seeded onto plates coated
with POL and POL-nHA. After 24 h, cells growing
on the POL-coated plates maintained a spherical form
(Figure 3A), whereas cells on the POL-nHA substrate
appeared to be attached firmly, as demonstrated by the
presence of numerous filopodia extensions (Figure 3B),
suggesting that the nHA particles improved osteoblast
adhesion and spreading. Moreover, images obtained
by AFM showed that hOBs cultured on POL/nHA ad-
hered stronger than those on POL alone, as shown
by the increase in nanometric superficial roughness
(Figure 3C-D).
Effects of nano-hydroxyapatite on gene expression of
human osteoblasts
RNA was extracted from cells cultured for 14 days on
both substrates (POL versus POL/nHA) and subjected to
real time RT-PCR to assess for changes in the expression
of specific osteoblastic differentiation genes (Table 1):
BMP-2, -5 and -7, ALP, COLL-1A2, OC and ON, well-
Figure 1 Human primary osteoblasts. (A) After 4 (B) After 5 days (C) After 14 days (Original magnification, 20×).
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BMP-2, BMP-5 and BMP-7 were increased by approxi-
mately 1.7, 4.5 and 4.3 times, respectively, in hOBs cul-
tured on POL/nHA substrates as compared with those
cultured on POL alone (p < 0.05). Interestingly, COLL-
1A2, OC and ON expression was 1.6, 1.9 and 2.1 times
higher, respectively, in hOBs grown on POL/nHA as com-
pared with those grown on POL (p < 0.01). ALP was also
increased 2.5 times in hOBs grown on POL/nHA (p <
0.01), suggesting an increase in differentiation of these
cells under the current culture conditions.
Overall, our results show that, within a 14-day time
frame, POL/nHA substrate can enhance the expression
of specific osteoblastic genes, which strongly indicates a
positive effect of nHA on osteoblast differentiation
(Figure 4).Figure 2 Scanning microscopy. (A) Electron microscopy image of the po
nanohydroxyapatite. (C) Scanning electron microscopy. (D) Atomic force mDiscussion
Hydroxyapatite, among the various bone grafting substi-
tutes, has been widely investigated in periodontal regen-
eration over the past three decades [4,20]. HA alloplastic
grafts, despite their similar chemical composition to
bone, are known mainly for their osteoconductive prop-
erties [5]. Our study has confirmed the osteoconductive
properties of a nano-sized version of this material, show-
ing that nHA can stimulate osteoblasts to produce se-
lected biomarkers representative of bone formation and
mesenchymal cell recruitment.
The rationale for the choice of human alveolar osteo-
blasts is based on the fact that these cells are located on
the bone surface of the defect, meaning that the grafted
material will be in direct contact with these osteoblasts
during healing. The cell collection method was performedlylysine (POL) substrates. (B) Atomic force microscopy of POL/
icroscopy of POL/nanohydroxyapatite (POL/nHA).
Figure 3 Scanning electron microscopy (SEM) and atomic force microscopy (AFM). (A) Cells grown on POL appeared spherical with
retracted fibers. (B) Cells grown on POL/nHA appeared elongated and with many filopodia. (C) Cells grown on POL appeared spherical with
retracted fibers. (D) Cells grown on POL/nHA appeared elongated and with many filopodia.
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nique used during resective periodontal surgery [21,22].
Cell culture and formation of the substrates were per-
formed followed models previously used (dispersion of
particles of nHA in poli-ethylene-glicol-dimethacrylate
or nHA associated with a polycarbonate, polyamide,
polysaccharide) [23-27]. Human alveolar osteoblasts are
the primary cells responsible for alveolar bone forma-
tion, although they do not appear to be able to migrate
and proliferate at distant sites where bone regeneration
is required. Albrektsson & Johansson suggested that
pre-existing osteoblastic cells only contribute a minor
portion of the new bone needed in a fracture healing
situation and that the recruitment of immature cells
and their differentiation into osteoblasts are probably
the basic and pivotal mechanism regulating bone heal-
ing [6]. Indeed, osteoblasts have been shown to contrib-
ute to the production of growth factors that encourageFigure 4 Gene expression of hOBs placed in culture in POL and POL/ncellular migration as well as the osteogenic and chon-
drogenic differentiation of mesenchymal progenitor
cells [28]. Our study demonstrates that nHA stimulates
the local alveolar osteoblasts to produce relevant bone-
specific BMPs, which are known to initiate and regulate
bone formation starting from the progenitor cells.
Several types of BMPs, which belong to the transform-
ing growth factor (TGF)-β family, have been investigated
and characterized for their modulatory role in bone tis-
sue homeostasis. BMP-2 and BMP-7 are of particular
interest, since they are naturally released in response to
trauma or during bone remodeling and are, to date, the
only known inductive agents [6]. Stimulation of BMP-2, -5
and -7 is an important aspect of osteogenesis, as these
proteins are the three of the most potent growth factors
enhancing bone formation. The results presented herein
show that nHA promotes BMP expression by alveolar os-
teoblasts in vitro. This observation suggests that nHAHA.
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defect site in two ways: by inducing osteogenic differenti-
ation as observed by Lock et al. [11] and/or by inducing
the secretion of specific factors, such as BMPs or other
growth factors not tested in this experiment. Moreover,
the nHA influenced a significant increase in the expres-
sion of several important markers of osteogenesis ALP,
OC, ON and COLL-1A2.
To instigate bone formation, cells need to adhere
and proliferate. Surface roughness is an important con-
sideration when selecting a bone-inducing substrate.
According to physical and mechanical principles, a sub-
strate with superficial roughness shows a higher cap-
acity for adhesion when compared with a smooth
surface [29-32]. In this study, osteoblast adhesion was
evaluated based on changes to the cell form and on the
presence of filopodia. SEM and AFM images showed
that nHA had a rougher surface than the control sub-
strate and favored the adhesion and proliferation of
human osteoblasts. These results are in agreement with
those reported by Thian et al., showing that nHA en-
hanced adhesion and spreading of human osteoblast-like
cells [33] and Liu et al., demonstrating the induction of
adhesion and proliferation of human osteoblast-like
MG-63 cells on nHA [14].
Conclusions
Within the limits of this study, we observed that nHA
can significantly increase on site human alveolar osteo-
blast adhesion and differentiation, and therefore specu-
late that nHA could encourage bone formation by local
osteoblasts at sites of alveolar bone reconstruction. In
addition, the increased expression of BMPs on the nHA
surface could indicate an increase in the recruitment of
progenitor cells during healing with nHA scaffolds.
These in vitro findings could explain, at least in part, the
new bone formation witnessed in bone defects filled
with nHA grafting material [34,35] and suggest the fur-
ther role of nHA in periodontal reattachment processes,
including the formation of new cementum and new peri-
odontal ligament. Further histological and clinical stud-
ies are needed to give significance to the in vitro results
as well as a biological explanation of the clinical out-
comes observed by others.
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